Investors Template
We see everyone within the Ipsen investor community as a valued stakeholder who helps drive our overall success. Dedicated to transparency and ethical decision-making, we aim to provide investors with the resources they need to understand our company and how we plan to reach our ambitious targets.
“Underpinned by a robust balance sheet and strong cash generation, we have the ambition to replenish our pipeline. With a successful strategy, we’re proud to be backed by an investor community that recognizes our positive progress.”
Strong results backed by innovation
Ipsen delivered strong results in 2022. With a geographically balanced model, we delivered growth across total sales and core operating income.
Entered the field in 1986
Ipsen entered the field of oncology in 1986, and today we have a portfolio including treatments for neuroendocrine.
Gained 75.1% of global sales
75.1% of Ipsen’s global sales are in oncology, making us one of the top global oncology companies.
We are in the treatment of NETs
In the U.S., we are bringing new insights to the treatment of NETs by applying Artificial Intelligence to our clinical trial data.
Careers at Ipsen
At Ipsen, we recognize that our employees are the cornerstone of our success. We offer exciting opportunities that will challenge your abilities, grow your career and reward your contribution while making a meaningful difference for patients and society.
Patients are the heart of everything we do. Our focus on the fields of oncology, rare disease and neuroscience enables us to develop an ever-greater understanding of patients’ needs and experiences.
PipelineInvestors
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.
Upcoming Events